Lily Cheung's most recent trade in Pliant Therapeutics Inc was a trade of 123,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Apr 2026 | 123,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2026 | 123,000 | 123,000 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Apr 2026 | 52,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2026 | 52,000 | 52,000 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2026 | 51,750 | 51,750 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Apr 2026 | 51,750 | 0 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 20 Jan 2026 | 7,534 | 44,847 | - | 1.3 | 9,644 | Common Stock |
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 51,750 | 51,750 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 25,875 | 50,425 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 17 Jan 2025 | 3,740 | 24,550 | - | 11.2 | 41,892 | Common Stock |
| Pliant Therapeutics Inc | Cheung Lily | Chief Human Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 52,000 | 52,000 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Cheung Lily | Chief Human Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 26,000 | 26,795 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 123,000 | 123,000 | - | - | Stock Option (Right to Buy) |